Acorda Therapeutics, Inc. (ACORQ)
Aug 22, 2024 - ACORQ was delisted (reason: shares cancelled)
0.0100
0.00 (0.00%)
Inactive · Last trade price
on Aug 23, 2024
Acorda Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | NaN - NaN |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 29.98 | 37.54 | 45.63 | 71.37 | 62.09 | Upgrade
|
| Short-Term Investments | - | - | - | - | 63.75 | Upgrade
|
| Cash & Short-Term Investments | 29.98 | 37.54 | 45.63 | 71.37 | 125.84 | Upgrade
|
| Cash Growth | -20.13% | -17.75% | -36.06% | -43.29% | -71.76% | Upgrade
|
| Receivables | 17.3 | 13.87 | 17 | 20.19 | 22.08 | Upgrade
|
| Inventory | 16.16 | 12.75 | 18.55 | 28.68 | 25.22 | Upgrade
|
| Prepaid Expenses | 5.21 | 4.31 | 6.57 | 14.81 | 11.57 | Upgrade
|
| Restricted Cash | 0.38 | 6.88 | 13.4 | 12.92 | 12.84 | Upgrade
|
| Other Current Assets | 5.77 | 6.77 | 1 | 73.37 | 3.56 | Upgrade
|
| Total Current Assets | 74.79 | 82.12 | 102.16 | 221.34 | 201.11 | Upgrade
|
| Property, Plant & Equipment | 6.3 | 7.89 | 11.13 | 25.74 | 165.98 | Upgrade
|
| Other Intangible Assets | 22.99 | 305.09 | 335.98 | 366.98 | 402.33 | Upgrade
|
| Other Long-Term Assets | 4.44 | 0.5 | 6.2 | 18.62 | 30.3 | Upgrade
|
| Total Assets | 108.53 | 395.6 | 455.47 | 632.68 | 799.72 | Upgrade
|
| Accounts Payable | 13.37 | 9.81 | 10.85 | 12.16 | 26.26 | Upgrade
|
| Accrued Expenses | 24.31 | 23.68 | 26.75 | 38.17 | 39.08 | Upgrade
|
| Current Portion of Long-Term Debt | 186.14 | - | 4.46 | 77.36 | 11.44 | Upgrade
|
| Current Portion of Leases | 1.59 | 1.55 | 8.19 | 7.94 | 7.75 | Upgrade
|
| Current Unearned Revenue | 0.23 | 0.38 | - | - | - | Upgrade
|
| Other Current Liabilities | 2.13 | 2.53 | 3.78 | 1.62 | 1.87 | Upgrade
|
| Total Current Liabilities | 227.77 | 37.95 | 54.03 | 137.25 | 86.39 | Upgrade
|
| Long-Term Debt | - | 167.03 | 178.67 | 172.7 | 231.83 | Upgrade
|
| Long-Term Leases | 3.17 | 4.34 | 4.09 | 17.2 | 23 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | 44.2 | 13.93 | 19.12 | 9.58 | Upgrade
|
| Other Long-Term Liabilities | 35.54 | 48.45 | 53.62 | 48.46 | 138.1 | Upgrade
|
| Total Liabilities | 266.48 | 301.97 | 304.33 | 394.73 | 488.9 | Upgrade
|
| Common Stock | 0 | 0.02 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 1,030 | 1,030 | 1,023 | 1,008 | 979.43 | Upgrade
|
| Retained Earnings | -1,189 | -936.27 | -870.36 | -766.4 | -666.81 | Upgrade
|
| Treasury Stock | -0.64 | -0.64 | -0.64 | -0.64 | -0.64 | Upgrade
|
| Comprehensive Income & Other | 1.43 | 0.63 | -1.02 | -2.8 | -1.17 | Upgrade
|
| Shareholders' Equity | -157.96 | 93.62 | 151.14 | 237.96 | 310.82 | Upgrade
|
| Total Liabilities & Equity | 108.53 | 395.6 | 455.47 | 632.68 | 799.72 | Upgrade
|
| Total Debt | 190.9 | 172.92 | 195.4 | 275.21 | 274.02 | Upgrade
|
| Net Cash (Debt) | -160.92 | -135.38 | -149.77 | -203.84 | -148.18 | Upgrade
|
| Net Cash Per Share | -129.56 | -133.91 | -282.02 | -504.30 | -373.85 | Upgrade
|
| Filing Date Shares Outstanding | 1.24 | 1.22 | 0.66 | 0.47 | 0.4 | Upgrade
|
| Total Common Shares Outstanding | 1.24 | 1.22 | 0.66 | 0.47 | 0.4 | Upgrade
|
| Working Capital | -152.98 | 44.17 | 48.13 | 84.08 | 114.73 | Upgrade
|
| Book Value Per Share | -127.17 | 76.94 | 228.23 | 502.54 | 781.92 | Upgrade
|
| Tangible Book Value | -180.94 | -211.47 | -184.84 | -129.03 | -91.51 | Upgrade
|
| Tangible Book Value Per Share | -145.68 | -173.78 | -279.13 | -272.49 | -230.21 | Upgrade
|
| Machinery | 5.64 | 7.6 | 24.06 | 27.8 | 61.39 | Upgrade
|
| Construction In Progress | - | - | - | 0.17 | 120.31 | Upgrade
|
| Leasehold Improvements | 2.02 | 1.76 | 15.32 | 15.32 | 25.31 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.